|
Á¢¼ö¹øÈ£ |
Çй®ºÐ¾ß |
¹ßÇ¥Çü½Ä |
ÃÊ·ÏÁ¦¸ñ |
¹ßÇ¥ÀÚ¡å |
ÃʷϹøÈ£ |
Æ÷½ºÅ͹øÈ£ |
ȸÀÇ½Ç |
½Ã°£ |
| 09-158 |
platelet/hemostasis |
Æ÷½ºÅÍ |
A novel splicing mutation in the ITGB3 gene in a Korean patient with Glanzmann thrombasthenia |
Á¤Çý¼± |
S-D-4 |
P-63 |
|
|
| 09-023 |
laboratory hematology |
Æ÷½ºÅÍ |
Immature Platelet Fraction (IPF) from SYSMEX 2100: Reference Ranges and Diagnostic Relevance in Thrombocytopenia
|
Á¤Çý¿µ |
F-G-1 |
P-73 |
|
|
| 09-050 |
others |
Æ÷½ºÅÍ |
Transient febrile pancytopenia associated with parvovirus 19 infection in a healthy adult person |
Á¤Èñ°æ |
Àü½Ã |
P-87 |
|
|
| 09-082 |
acute leukemia |
Æ÷½ºÅÍ |
Infantile leukemia with MLL-AF4 switched lineage at relapse with persistence of this rearrangement |
Á¤Èñ¿µ |
F-B-4 |
P-23 |
|
|
| 09-005 |
stem cell transplantation |
±¸¿¬ |
The incidence, risk and prognostic factors for thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation based on recent proposed consensus criteria |
Á¶º´½Ä |
O1-1 |
|
A |
14:30 ~ 14:40 |
| 09-022 |
lymphoma/plasma cell dyscrasia |
Æ÷½ºÅÍ |
A comparison between myelomatous and non-myelomatous pleural effusion: IgD myeloma with a predilection for myelomatous pleural effusion
|
Á¶¿µ¿í |
F-D-4 |
P-43 |
|
|
| 09-125 |
laboratory hematology |
Æ÷½ºÅÍ |
±Þ¼º AÇü °£¿°°ú µ¿¹ÝµÈ ½ÉÇÑ EDTA-ÀÇÁ¸¼º À§¼ºÇ÷¼ÒÆÇ°¨¼ÒÁõ 1¿¹ |
Á¶¿µ¿í |
Àü½Ã |
P-79 |
|
|
| 09-149 |
laboratory hematology |
Æ÷½ºÅÍ |
A case of parvo viral infection induced anemia in liver transplantation recipient |
Á¶¿ë±Ù |
Àü½Ã |
P-80 |
|
|
| 09-012 |
acute leukemia |
Æ÷½ºÅÍ |
A Case of Therapy-related Acute Lymphoblastic Leukemia Following Topoisomerase II Inhibitor Treatment for Breast Cancer
|
Á¶ÁøÈñ |
Àü½Ã |
P-27 |
|
|
| 09-013 |
others |
Æ÷½ºÅÍ |
Multiple unrelated chromosomal abnormalities after cord blood transplantation |
Á¶ÁøÈñ |
Àü½Ã |
P-86 |
|
|
| 09-011 |
stem cell transplantation |
±¸¿¬ |
Impact of Vitamin D Receptor Gene Polymorphisms on Clinical Outcomes of Sibling HLA-matched Hematopoietic Stem Cell Transplantation |
Á¶ÇöÁø |
O1-3 |
|
A |
14:50 ~ 15:00 |
| 09-027 |
lymphoma/plasma cell dyscrasia |
Æ÷½ºÅÍ |
¹éÇ÷º´ ¾ç»óÀ¸·Î ¹ßÇöµÈ ºñÀå Mantle Cell Lymphoma 1¿¹ º¸°í |
Áö¹Ì¼÷ |
Àü½Ã |
P-50 |
|
|
| 09-138 |
lymphoma/plasma cell dyscrasia |
±¸¿¬ |
¸¸¼º¸²ÇÁ±¸¹éÇ÷º´°ú Àü¸²ÇÁ±¸¹éÇ÷º´ÀÇ ZAP-70 ¹ßÇö ¾ç»óµî °Ë»ç ¹× ÀÓ»óÀû Ư¡
|
Áö¹Ì¼÷ |
O5-12 |
|
B |
17:40 ~ 17:50 |
| 09-025 |
lymphoma/plasma cell dyscrasia |
Æ÷½ºÅÍ |
´Ù¹ß¼º ±¹¼Ò °ñ°æÈÁõÀ» µ¿¹ÝÇÑ ´Ù¹ß¼º°ñ¼öÁ¾ |
Áø¼±¾Æ |
Àü½Ã |
P-49 |
|
|
| 09-134 |
laboratory hematology |
Æ÷½ºÅÍ |
JAK2 V617F µ¹¿¬º¯ÀÌ °ËÃâÀ» À§ÇÑ BsaXI Á¦ÇÑÈ¿¼Ò ó¸® PCR ¹× Á÷Á¢ ¿°±â¼¿ºÐ¼®¹ýÀÇ À¯¿ë¼º |
Áø¿ø¿µ |
F-G-4 |
P-76 |
|
|